It’s made an appearance during hockey, basketball, and baseball games, popped up during an episode of your favourite reality show and has even snuck in between segments of the nightly news. Fighting…

Nathan and Andre needed a game-changing gene-specific therapy. But the costs were astronomical and the parents were at a loss. Here’s how I witnessed their story go from tragic to triumphant. Twins…

Nick D’Ambrosio is a 51-year-old Italian Canadian from Montréal, Québec living with sight loss due to an inherited retinal disease called retinitis pigmentosa (RP). Following an early diagnosis, Nick found it difficult…

Starting in 2023, a new clinical trial called NAC Attack will be launched to test an oral medication, N-acetylcysteine (NAC), as a potential therapy for patients with retinitis pigmentosa (RP). NAC Attack…

Dr. Sachdev Sidhu (University of Toronto) is a biomedical engineer with extensive experience in drug development. Dr. Sidhu established the Toronto Recombinant Antibody Centre (TRAC) which houses a state-of-the-art platform to generate…

Teamwork really does make the dream work! We are excited to share news of a Fighting Blindness Canada (FBC) funded discovery recently published in the journal Science Advances achieved through a collaboration…